Inventor · disambiguated record
Xinli Lin
Also filed as: LIN XINLI · LIN XINLI HENRY
7 granted patents·15 pending applications·157 citations·filing 1997–2024
87Inventor score
Files withOKLAHOMA MED RES FOUND8LIN XINLI7Shenzhen Bay Laboratory3UNIV BEIJING1UNIVERSAL BIO RESEARCH CO LTD1
Top patents by PatentIndex Score
22 records- 0194US6545127B1Catalytically active recombinant memapsin and methods of use thereofOKLAHOMA MED RES FOUND·Filed 2000·Granted Apr 8, 2003·85 cites·18 claims
- 0286US7829669B2Catalytically active recombinant memapsin and methods of use thereofOKLAHOMA MED RES FOUND·Filed 2007·Granted Nov 9, 2010·7 cites·7 claims
- 0386US6583268B2Universal procedure for refolding recombinant proteinsOKLAHOMA MED RES FOUND·Filed 2000·Granted Jun 24, 2003·20 cites·15 claims
- 0482US7119166B2Universal procedure for refolding recombinant proteinsOKLAHOMA MED RES FOUND·Filed 2003·Granted Oct 10, 2006·12 cites·25 claims
- 0567US11964004B2Short in vivo half-life and in vivo unstable recombinant microplasmin, pharmaceutical composition comprising thereof and method of treating thromboembolism related diseases including administration thereofShenzhen Bay Laboratory·Filed 2022·Granted Apr 23, 2024·0 cites·7 claims
- 0667US2025090644A1E. coli expressed recombinant human microplasmin, a production method thereof, a pharmaceutical composition and a kit comprising thereof, a method and an application of treating thromboembolism related diseases by using thereofShenzhen Bay Laboratory·Filed 2024·Application pending·0 cites
- 0764US2006287504A1Universal procedure for refolding recombinant proteinsOKLAHOMA MED RES FOUND·Filed 2006·Application pending·0 cites
- 0862US6303380B1Construction of retroviral producer cells from adenoviral and retroviral vectorsOKLAHOMA MED RES FOUND·Filed 1999·Granted Oct 16, 2001·17 cites·12 claims
- 0958US6225103B1Cloning and characterization of napsinOKLAHOMA MED RES FOUND·Filed 1997·Granted May 1, 2001·16 cites·11 claims
- 1055US2004265298A1Methods for production of recombinant urokinaseLIN XINLI·Filed 2004·Application pending·0 cites
- 1153US2020354433A1RECOMBINANT MUTANT (alpha)1-ANTITRYPSIN AND PREPARATION AND USES THEREOFUNIV BEIJING·Filed 2020·Application pending·0 cites
- 1253US2005037486A1Apparatus for refolding proteins and method of using sameUNIVERSAL BIO RESEARCH CO LTD·Filed 2004·Application pending·0 cites
- 1353US2005227920A1Methods for production of recombinant vascular endothelial cell growth inhibitorLIN XINLI·Filed 2004·Application pending·0 cites
- 1451US2021121419A1Metformin compounded composition and method thereofZHOUSHAN TRITECH BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1551US2005233961A1Methods for treating cancer using vascular endothelial cell growth inhibitor VEGI-192ALIN XINLI·Filed 2004·Application pending·0 cites
- 1650US2007009506A1Methods for production of recombinant urokinaseLIN XINLI·Filed 2006·Application pending·0 cites
- 1749US2002164760A1Catalytically active recombinant memapsin and methods of use thereofOKLAHOMA MED RES FOUND·Filed 2001·Application pending·0 cites
- 1849US2012165268A1P53 fusion proteins and methods of making and using thereofLIN XINLI·Filed 2009·Application pending·0 cites
- 1946US2010144622A1Methods for production of recombinant plasminogen and plasmin polypeptidesLIN XINLI·Filed 2007·Application pending·0 cites
- 2044US2007218535A1Methods for production of recombinant alpha1-antitrypsinLIN XINLI·Filed 2006·Application pending·0 cites
- 2143US2002049303A1Catalytically active recombinant memapsin and methods of use thereofFiled 2001·Application pending·0 cites
- 2242US2021330762A1Medical application of mutant plasminogen and plasmin polypeptide therapeuticsShenzhen Bay Laboratory·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xinli Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →